Inhibition of anthralin-caused skin tumor promotion and interleukin-1α production by potent immunosuppressant FK506
- 15 August 1994
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 83 (1-2) , 185-189
- https://doi.org/10.1016/0304-3835(94)90317-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Interleukin‐1α gene expression and localization of interleukin‐1α protein during tumor promotionMolecular Carcinogenesis, 1993
- Anti-tumor-promoting action of FK506, a potent immunosuppressive agentCarcinogenesis: Integrative Cancer Research, 1993
- Modulation of interleukin‐1α mRNA expression in mouse epidermis by tumor promoters and antagonistsMolecular Carcinogenesis, 1993
- FK-506 enters the clinicImmunology Today, 1990
- Differential inhibition by staurosporine, a potent protein kinase C inhibitior, of 12-O-tetradecanoylphorbol-13-acetate-caused skin tumor promotion, epidermal ornithine decarboxylase induction, hyperplasia and inflammationCarcinogenesis: Integrative Cancer Research, 1989
- Interleukin 1 binds to specific receptors on human keratinocytes and induces granulocyte macrophage colony-stimulating factor mRNA and protein. A potential autocrine role for interleukin 1 in epidermis.Journal of Clinical Investigation, 1988
- PROLONGATION OF SKIN ALLOGRAFT SURVIVAL IN RATS BY A NOVEL IMMUNOSUPPRESSIVE AGENT, FK 506Transplantation, 1988
- STUDIES OF THE INDUCTION AND MAINTENANCE OF LONG-TERM GRAFT ACCEPTANCE BY TREATMENT WITH FK506 IN HETEROTOPIC CARDIAC ALLOTRANSPLANTATION IN RATSTransplantation, 1987
- Human keratinocytes contain mRNA indistinguishable from monocyte interleukin 1 alpha and beta mRNA. Keratinocyte epidermal cell-derived thymocyte-activating factor is identical to interleukin 1.The Journal of Experimental Medicine, 1986
- INHIBITION OF DITHRANOL INFLAMMATION BY FREE-RADICAL SCAVENGERSThe Lancet, 1984